Table 2.
Baseline and after-treatment outcome measures.
| Robot group (n = 26) | Control group (n = 23) | |||||
|---|---|---|---|---|---|---|
| Pre | Post | P value* | Pre | Post | P value* | |
| FAC | 0.96 ± 0.87 | 3.35 ± 1.23 | <.001 | 1.04 ± 0.93 | 2.48 ± 1.12 | <.001 |
| MI | 53.19 ± 15.57 | 67.54 ± 14.28 | <.01 | 43.48 ± 18.11 | 56.09 ± 13.47 | <.01 |
| FMA-LE | 19.85 ± 8.92 | 27.42 ± 4.87 | <.01 | 16.13 ± 8.83 | 21.65 ± 7.86 | <.01 |
| RMI | 4.35 ± 2.64 | 9.15 ± 2.95 | <.01 | 3.91 ± 2.17 | 8.30 ± 2.74 | <.01 |
| 10MWT (m/s) | 0.30 ± 0.26 | 0.60 ± 0.36 | <.01 | 0.22 ± 0.13 | 0.43 ± 0.29 | <.01 |
| BBS | 25.08 ± 22.67 | 47.58 ± 21.33 | <.01 | 19.65 ± 21.25 | 38.87 ± 22.56 | <.01 |
| MBI | 34.50 ± 16.82 | 63.85 ± 19.52 | <.01 | 34.48 ± 16.60 | 60.87 ± 21.45 | <.01 |
10MWT = 10 meter walk test, BBS = Berg balance scale, FAC = functional ambulatory category, FMA-LE = Fugl Meyer assessment-lower extremity, MBI = modified Barthel index, MI = motricity index-lower extremity, RMI = rivermead mobility index.
Wilcoxon signed rank test.